Most cited papers from Olgahospital

Olgahospital

What are the most cited papers from Olgahospital?

The most cited paper from Olgahospital is "Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2" (Dennis J. Slamon, Brian R Leyland-Jones, Steven Shak et al., 2001), with 11,628 citations. Next come "Adjuvant Trastuzumab in HER2-Positive Breast Cancer" (2,803) and "The landscape of genomic alterations across childhood cancers" (1,654).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 233 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2 Dennis J. Slamon, Brian R Leyland-Jones, Steven Shak et al. · New England Journal of Medicine Open access	15 Mar 2001	11,628
2	Adjuvant Trastuzumab in HER2-Positive Breast Cancer Dennis J. Slamon et al. · New England Journal of Medicine Open access	5 Oct 2011	2,803
3	The landscape of genomic alterations across childhood cancers ICGC PedBrain-Seq Project et al. · Nature Open access	28 Feb 2018	1,654
4	Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up Paolo Giovanni Casali et al. · Annals of Oncology Open access	28 Mar 2018	1,636
5	Association analysis identifies 65 new breast cancer risk loci Kyriaki Michailidou et al. · Nature Open access362 authors	20 Oct 2017	1,602
6	Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort Luca Gianni, Wolfgang EIERMANN, Владимир Федорович Семиглазов et al. · The Lancet	2010	1,276
7	Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes Nasim Mavaddat et al. · The American Journal of Human Genetics Open access269 authors	13 Dec 2018	1,213
8	Osteosarcoma Jörg Ritter, Stefan S. Bielack · Annals of Oncology Open access	Oct 2010	1,085
9	Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆ Alessandro Gronchi et al. · Annals of Oncology Open access	22 Jul 2021	1,057
10	Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials David S. Hong et al. · The Lancet Oncology Open access	24 Feb 2020	1,026
11	Dissecting the genomic complexity underlying medulloblastoma David Jones et al. · Nature Open access	24 Jul 2012	884
12	Shear-wave Elastography Improves the Specificity of Breast US: The BE1 Multinational Study of 939 Masses Wendie A. Berg, David Owen Cosgrove, Caroline J Doré et al. · Radiology	26 Jan 2012	844
13	Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up Paolo Giovanni Casali et al. · Annals of Oncology Open access	28 Mar 2018	759
14	Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort Sigbjørn Smeland et al. · European Journal of Cancer Open access	27 Jan 2019	748
15	Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Pancras C.W. Hogendoorn, Nick A. Athanasou, S. Bielack et al. · Annals of Oncology Open access	May 2010	721
16	Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study Wolfgang EIERMANN, Stefan Paepke, Justus Appfelstaedt et al. · Annals of Oncology Open access	Nov 2001	719
17	Osteosarcoma Hannah C. Beird, Stefan S. Bielack, Adrienne Margaret Flanagan et al. · Nature Reviews Disease Primers ReviewOpen access	8 Dec 2022	659
18	Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up Paolo Giovanni Casali et al. · Annals of Oncology Open access	2 Aug 2018	655
19	Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up Paolo Giovanni Casali et al. · Annals of Oncology Open access	21 Sep 2021	608
20	Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial Neyssa M. Marina et al. · The Lancet Oncology Open access	31 Aug 2016	559
21	Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up Sandra J. Strauss et al. · Annals of Oncology Open access	6 Sep 2021	485
22	High-resolution tensor MR elastography for breast tumour detection Ralph Sinkus, J. Lorenzen, D Schrader et al. · Physics in Medicine and Biology Open access	19 May 2000	478
23	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer ABCTB Investigators et al. · Nature Genetics Open access476 authors	23 Oct 2017	477
24	Loss of Interleukin-10 Signaling and Infantile Inflammatory Bowel Disease: Implications for Diagnosis and Therapy Daniel Kotlarz et al. · Gastroenterology Open access	30 Apr 2012	476
25	Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial Wolfgang Göpel, Angela Kribs, Andreas Ziegler et al. · The Lancet	30 Sep 2011	475
26	Neuroblastoma Screening at One Year of Age Freimut H. Schilling, Claudia Spix, Frank Berthold et al. · New England Journal of Medicine Open access	4 Apr 2002	464
27	Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease Yael Hacohen et al. · JAMA Neurology Open access	5 Jan 2018	425
28	2020 WHO Classification of Female Genital Tumors Anne Kathrin Höhn, Christine Brambs, Grit Gesine Ruth Hiller et al. · Geburtshilfe und Frauenheilkunde Open access	Oct 2021	416
29	Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial Frank Berthold, Joachim Boos, Stefan E.G. Burdach et al. · The Lancet Oncology	12 Aug 2005	402
30	Nonintubated Surfactant Application vs Conventional Therapy in Extremely Preterm Infants Angela Kribs, Claudia Roll, Wolfgang Göpel et al. · Archives of Pediatrics and Adolescent Medicine Open access	8 Jun 2015	374
31	Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency Michal B Kovac et al. · Nature Communications Open access	3 Dec 2015	354
32	Next-generation personalised medicine for high-risk paediatric cancer patients – The INFORM pilot study Barbara Christine Worst et al. · European Journal of Cancer Open access	29 Jul 2016	342
33	EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment Jeremy Whelan et al. · Annals of Oncology Open access	24 Nov 2014	341
34	Targeted next generation sequencing as a diagnostic tool in epileptic disorders Johannes R. Lemke et al. · Epilepsia	21 May 2012	332
35	The German etanercept registry for treatment of juvenile idiopathic arthritis Gerd Horneff, H Schmeling, T Biedermann et al. · Annals of the Rheumatic Diseases Open access	4 May 2004	325
36	Localized Infant Neuroblastomas Often Show Spontaneous Regression: Results of the Prospective Trials NB95-S and NB97 Barbara Hero, Thorsten Simon, Ruediger Spitz et al. · Journal of Clinical Oncology	18 Mar 2008	309
37	Phosphorylation of histone H3T6 by PKCβI controls demethylation at histone H3K4 Eric Metzger, Axel Imhof, Dharmeshkumar Patel et al. · Nature	14 Mar 2010	302
38	Treatment of breast cancer during pregnancy: an observational study Sibylle Loibl et al. · The Lancet Oncology	16 Aug 2012	298
39	Effect of neoadjuvant anthracycline–taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study Jens Huober, Gϋnter von Minckwitz, Carsten Denkert et al. · Breast Cancer Research and Treatment	9 Aug 2010	298
40	An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane Aman U. Buzdar, John F.R. Robertson, Wolfgang EIERMANN et al. · Cancer Open access	25 Oct 2002	296
41	Childhood cancer predisposition syndromes—A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology Tim Ripperger et al. · American Journal of Medical Genetics Part A Open access	7 Feb 2017	289
42	Adolescents and young adults (AYA) with cancer: a position paper from the AYA Working Group of the European Society for Medical Oncology (ESMO) and the European Society for Paediatric Oncology (SIOPE) Andrea C. Ferrari, Dan Stark, Fedro Alessandro Peccatori et al. · ESMO Open Open access	Apr 2021	287
43	Bone tumours in European children and adolescents, 1978–1997. Report from the Automated Childhood Cancer Information System project Charles A. Stiller, Stefan S. Bielack, Gernot Jundt et al. · European Journal of Cancer	18 Aug 2006	286
44	Salt Wasting and Deafness Resulting from Mutations in Two Chloride Channels Karl P. Schlingmann, Martin Konrad, Nikola Jeck et al. · New England Journal of Medicine Open access	24 Mar 2004	286
45	Osteosarcoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up Stefan S. Bielack, Dorothe Carrle, Paolo Giovanni Casali · Annals of Oncology Open access	May 2009	280
46	The Effect of Epoetin Beta (Recombinant Human Erythropoietin) on the Need for Transfusion in Very-Low-Birth-Weight Infants Rolf F. Maier, Michael Obladen, P. Scigalla et al. · New England Journal of Medicine Open access	28 Apr 1994	273
47	The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets Cornelis Martinus van Tilburg et al. · Cancer Discovery Open access	9 Aug 2021	270
48	Effects of Liberal vs Restrictive Transfusion Thresholds on Survival and Neurocognitive Outcomes in Extremely Low-Birth-Weight Infants Axel Rainer Franz et al. · JAMA Open access150 authors	11 Aug 2020	266
49	GRIN2B encephalopathy: novel findings on phenotype, variant clustering, functional consequences and treatment aspects Konrad Platzer et al. · Journal of Medical Genetics Open access	4 Apr 2017	261
50	Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations Leanne de Kock et al. · Acta Neuropathologica Open access	19 May 2014	259

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.